DEALE-ing with Lung Cancer and Heart Failure

Beck JR , Pauker SG , Gottlieb JE , Klein K , Kassirer JP . A convenient approximation of life expectancy (the “DEALE”). II. Use in medical decision-making. Am J Med. 1982;73(6):889-897.

Beck JR , Kassirer JP , Pauker SG . A convenient approximation of life expectancy (the “DEALE”). I. Validation of the method. Am J Med. 1982;73(6):883-888.

Arias E. National Vital Statistics Report, Vol. 52, No. 14. United States Life Tables, 2001. Hyattsville (MD): National Center for Health Statistics; 2004.

Wang TJ , Larson MG , Levy D , et al . Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920-2925.

Nohria A , Tsang SW , Fang JC , et al . Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure [see Comment]. J Am Coll Cardiol. 2004;41(10):1797-1804.

Poole-Wilson PA , Swedberg K , Cleland JG , et al . Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362(9377):7-13.

Johnson D , Jin Y , Quan H , Cujec B . Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol. 2004;42(8):1438-1445.

Lee DS , Austin PC , Rouleau JL , Liu PP , Naimark D , Tu JV . Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290(19):2581-2587.

Moss AJ , Zareba W , Hall WJ , et al . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-883.

Moss AJ , Hall WJ , Cannom DS , et al . Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335(26):1933-1940.

Bigger JT Jr . Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronaryartery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337(22):1569-1575.

Mountain CF . The international system for staging lung cancer. Semin Surg Oncol. 2000;18(2):106-115.

Ginsberg RJ , Rubinstein LV . Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615-622.

Port JL, Kent MS , Korst RJ , Libby D , Pasmantier M , Altorki NK . Tumor size predicts survival within stage IA non-small cell lung cancer. Chest. 2004;124(5):1828-1833.

Ambrogi V , Pompeo E , Elia S , Pistolese GR , Mineo TC . The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer [see Comment]. Eur J Cardio Thorac Surg. 2003;23(5):811-817.

Okada M , Nishio W , Sakamoto T , et al . Evolution of surgical outcomes for non-small cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. Ann Thorac Surg. 2004;77(6):1926-1930.

Keller SM , Vangel MG , Wagner H , et al . Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg. 2004;128(1):130-137.

Walker WS , Codispoti M , Soon SY , Stamenkovic S , Carnochan F , Pugh G . Long-term outcomes following VATS lobectomy for non-small cell bronchogenic carcinoma. Eur J Cardio Thorac Surg. 2003;23(3):397-402.

Sugi K , Kaneda Y , Esato K . Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg. 2000;24(1):27-30.

Chang MY , Sugarbaker DJ. Surgery for early stage non-small cell lung cancer. Semin Surg Oncol. 2003;21(2):74-84.

Cheung PC , Mackillop WJ , Dixon P , Brundage MD , Youssef YM , Zhou S . Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2000;48(3):703-710.

Rowell NP , Williams CJ . Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax. 2001;56(8):628-638.

McGarry RC , Song G , des Rosiers P , Timmerman R . Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121(4):1155-1158.

Chadha AS , Sohi JS , Sahmoun AE , Alshehadat S , Mehdi S. Survival in untreated early non-small cell lung cancer: a retrospective analysis (abstract). Society of Surgical Oncology 2004.

Daniels LJ , Balderson SS , Onaitis MW , D’Amico TA . Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. Ann Thorac Surg. 2002;74(3):860-864.

Goldman L , Caldera DL , Nussbaum SR , et al . Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297(16):845-850.

van den Hout WB , Houwelingen JCV , Noordijk EM , Kramer GWPM , Leer JWH . Extrapolating utility and cost data in terminally ill patients: a pragmatic modeling approach (abstract). Presented at the annual meeting of the Society for Medical Decision Making; 2004 Oct 17-20; Atlanta, GA.

Keeney RL , Raiffa H. Decisions with Multiple Objectives: Preferences and Value Tradeoffs [Wiley Series in Probability and Mathematical Statistics]. New York: John Wiley; 1976.

National Cancer Institute . Surveillance, Epidemiology, and End Results Program (SEER) US Population Data—1969-2000. Washington (DC): National Cancer Institute; 2004.

Durand-Zaleski I , Zaleski S . DEALE-ing and discounting: a simple way to compute the accrued costs of preventive strategies. Med Decis Making. 1994;14(1):98-103.

von Neumann J , Morgenstern O. Theory of Games and Economic Behavior 3rd ed. Princeton (NJ): Princeton University Press; 1953.

Cohen BJ . Is expected utility theory normative for medical decision making? Med Decis Making. 1996;16(1):1-6.